Oleyloxyethylphosphorylcholine is an inhibitor of secretory phospholipase A2 (sPLA2), which is involved in the biosynthesis of pro-inflammatory lipid mediators; it can be used in the study of inflammatory diseases; it can also modify red blood cell membranes to encapsulate oxygen-carrying perfluorocarbon liquids for use as an antivenom agent to reduce toxin-induced hemolysis.